Depo‑Medrol 40 mg


Suspension for injection
scheduling status
S4
registration number
C726 (Act 101/1965)
What Depo‑Medrol 40 mg contains
Methylprednisolone acetate.
other ingredients
Polyethylene glycol Sodium chloride Myristyl‑gamma‑picolinium chloride Water for injection Excipients with known effect None stated Product is explicitly described as sugar‑free.
Therapeutic classification
A 3.1 – Antirheumatics (anti‑inflammatory medicines).
© 2026 SAHPRA. ALL RIGHTS RESERVED